Quote Schedule for Medical BPA Testing.xlsx
XLSX spreadsheet 16 KB Posted
- Attached to
- Medical Testing BPA Federal contract opportunity
- Solicitation number
- FA665625Q0007
About this file
This is a Quote Schedule for a Medical Blanket Purchase Agreement (BPA) for medical testing services at Youngstown Air Reserve Station, covering a five-year period from 01 May 2025 to 30 April 2030. The comprehensive medical testing scope includes numerous services such as DOT and non-DOT drug screenings, physical exams, functional assessments, laboratory tests (CBC, metabolic panels, lipid panels), specialized occupational health screenings (respiratory fit testing, audiograms, vision tests), vaccinations, and various medical evaluations for reservist and civilian firefighter personnel.
The solicitation (FA665625Q0007) is a full and open competition commercial service procurement under NAICS code 621999 with a $20.5 million small business size standard. The Air Force Reserve Command intends to award a single BPA to the lowest price technically acceptable offer, with quotes due by 10:00 a.m. EST on 14 April 2025. Submission options include email to ashley.senich@us.af.mil or mail to the specified address. Payment will be made via Government Purchase Card, and while a BPA establishment is not a guarantee of future calls, the government intends to utilize the agreement for repetitive medical testing needs.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Questions and Answers02 04.03.2025.docx | DOCX document | |
| Questions and Answers 01.docx | DOCX document | |
| Statement of Work Medical Testing BPA.docx | DOCX document | |
| Wage Determination 2015-4263.docx | DOCX document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Medical Testing BPA Quote | |||||||
| Youngstown Air Reserve Station | |||||||
| Company Name: | |||||||
| Cage Code: | |||||||
| UEI: | |||||||
| Unit Price | Unit Price | Unit Price | Unit Price | Unit Price | |||
| Period of Performance | Service | Description | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
| 01 May 2025-30 April 2030 | DOT Drug Screen | (5000) | |||||
| 5 Panel Non‐DOT Drug Screen | (3499) | ||||||
| 11 Panel Expanded Opiate | (1684) | ||||||
| Vital Signs | Blood Pressure, Pulse, Temperature, Height, Weight, Body Mass Index, Respiratory Rate | ||||||
| Complete Physical Exam with DO/MD Review and Qualification | Workplace Specific Pre-Selection, baseline, periodic and termination exams. | ||||||
| Partial Physical Exam with DO/MD Review and Qualification | Workplace Specific Pre-Selection, baseline, periodic and termination exams. Some components completed at YARS | ||||||
| DO/MD Review and Qualification | Workplace Specific Pre-Selection, baseline, periodic and termination exams. Exam completed at YARS but reqiures Contractor DO/MD review | ||||||
| Functional Assessment | Evaluate lifting, carrying, pulling, pushing, reaching, use of both hands, walking, standing, crawling, kneeling, bending, climbing, mental/muscular coordination, ability to perform strenuous activity, ability to perform physical agility testing | ||||||
| CBC (DIFF/PLT) | Lab: W/Smear code: 0020253 | ||||||
| CBC with Diff | Lab: CPT Code: 85025 | ||||||
| Complete Metabolic Panel (CMP) | Lab Code: 10231 CPT Code: | ||||||
| Renal (Kidney Function) Panel | Lab CPT Code: 80069 | ||||||
| Lipid (cholesterol) Panel | Lab CPT Code: 80061 | ||||||
| OSHA Respirator Questionnaire | Administration & Medical Review | ||||||
| Respiratory Fit Testing | Workplace Specific Mask (i.e. M-7 firehawk, 3M 6000 &7000, M-100…) | ||||||
| Firefighter Questionnaire | Administration & Medical Review | ||||||
| Occupational Spirometry | must include: FVC, FEV1, FEV1/FVC, Annotate possible obstructive/ restrictive conditions | ||||||
| Occular Exam | |||||||
| Ophthalmoscopy | Fundoscopic evaluation to visualize blood vessels and |
assess retinal vasculature for changes or abnormalities.
| Near Visual Accuity | Jaeger or equivalent |
| Distant Visual Accuity | Snellen or equivalent |
| Perepherial Vision | By Confrontational Fields or equivalent |
| Color Vision | Ishihara or equivalent |
| Amsler Grid | |
| Baseline Audiogram documented on DD2215 | AFI48-127, OSHA, NIOSH compliant |
| Annual Audiogram documented on DD2216 | AFI48-127, OSHA, NIOSH compliant |
| Chest Radiograph (X‐Ray) | 1 View |
| Chest Radiograph (X‐Ray) | 2 View (PA/LAT) |
| TB Test | Mantoux‐ 1-2 Step PPD |
| TB Test | Blood draw: QuantiFERON TB-Gold, CPT 86480 (or similare IGRA test) |
| Hepatitis A Vaccine | Complete Series IAW CDC Guidance |
| Hepatitis A Titer | |
| Hepatitis B Vaccine | Complete Series IAW CDC Guidance |
| Hepatitis B Titer | |
| ASCVD Risk Score | Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score (10-year Risk Assessment) |
| Fasting Blood Sugar | Fasting Glucose |
| ABO/RH Blood Type | Lab code: 4848 |
| ECG/EKG | 12-lead with interpretation |
| Blood Alcohol Ethyl | Lab Code: 443 |
| Tetanus Diptheria IGG | Code: 4042 |
| G‐6‐PD (B) | |
| Sickle Cell Screen | Hemoglobin S |
| Cholinesterase RBC | Lab CPT Code: 82482 |
| Cholinesterase Serum/Plasma | Lab CPT Code: 82480 |
| Insure | Superior to Hemoccult‐ Code: z13‐9 |
| HIV Blood Draw | HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes (Lab CPT Code: 87389) |
| Syphilis Serology | RPR Rflx to Titer, FTA-ABS Code: 36126, CPT: 86592, 86593, 86780 |
| Hemoglobin A1C | Blood draw |
| Mental Health Exam | Mini Teng Mini-Mental State Exam or equivalent, review psychiatric/psychological diagnoses, conditions, and symptoms that may adversely impact behavior |
| Pregnancy Test (hCG) Urine | CPT code: 81025 |
| Pregnancy Test (hCG) Serum | CPT code: 84703 |
| ZPP | Lab Code: 0000948, CPT 84202 |
| Cadmium | Lab Code: 0000299, CPT 82300 |
| Lead Whole/ Blood | Code: 0003058, CPT 83655 |
| Urinalysis Complete | Lab Code: 0005463, CPT 81001, ph, specific gravity, protein, glucose, ketones, blood, red blood cells, white blood cells |
| Urine Beta 2 Microalbumin | Code: 0004944, CPT 82232 |
| Urinalysis Microscopic | CPT code: 81015 |
| Urinalysis (Dipstick Microscopy) | CPT code: 81000 or 81001 |
| Cadmium Random Urine | |
| TDAP | Vaccine |
| TDAP Titer | |
| TD | Vaccine |
| TD Titer | |
| Hepatic (liver) Function test | Lab Code: 10256 |
| PFAS/PFOA | CPT Code: 82542 Compounds Tested must include: Perfluorooctanoic acid – linear isomers, Perfluoroctanoic acid branched isomers, Perfluorodecanoic acid, Perfluorohexanesulfonic acid, Perfluoroheptanesulfonic acid, Perfluorododecanoic acid, Perfluoroundecanoic acid, Perfluorohexanoic acid, Perfluorononanoic acid, Perfluorooctane sulfonate – linear isomers, Perfluorooctane sulfonate – branched isomers |
| Blood Borne Pathogen Post Exposure Evaluation | Ensure protocol follows current CDC recommendations |
| Occupational Post Exposure Evaluation | Determine & Implement appropriate post exposure protocols following workplace hazard exposure |
| Fitness for Duty Evaluation | Determine if an employee should be removed from duty and recommend duty restrictions |
| Medical History Review | Administration & Provider Review |
| Interium Health History Review | Administration & Provider Review |
| Occupational Illness/Injury Evaluation | Determine workplace relatedness, medical recommendations relating to duty restrictions |
| Review results with employee | Communicate results of exam with employee. Notify employee of abnormal results within 5 buisness days of idenfitication |
File details come from the government source that posted it. Updated .